Cargando…
Defining the Signature of VISTA on Myeloid Cell Chemokine Responsiveness
The role of negative checkpoint regulators (NCRs) in human health and disease cannot be overstated. V-domain Ig-containing Suppressor of T-cell Activation (VISTA) is an Ig superfamily protein predominantly expressed within the hematopoietic compartment and has been studied for its role in the negati...
Autores principales: | Broughton, Thomas W. K., ElTanbouly, Mohamed A., Schaafsma, Evelien, Deng, Jie, Sarde, Aurélien, Croteau, Walburga, Li, Jiannan, Nowak, Elizabeth C., Mabaera, Rodwell, Smits, Nicole C., Kuta, Anna, Noelle, Randolph J., Lines, J. Louise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877598/ https://www.ncbi.nlm.nih.gov/pubmed/31803182 http://dx.doi.org/10.3389/fimmu.2019.02641 |
Ejemplares similares
-
VISTA: A Target to Manage the Innate Cytokine Storm
por: ElTanbouly, Mohamed A., et al.
Publicado: (2021) -
VISTA Re-programs Macrophage Biology Through the Combined Regulation of Tolerance and Anti-inflammatory Pathways
por: ElTanbouly, Mohamed A., et al.
Publicado: (2020) -
A New VISTA on combination therapy for negative checkpoint regulator blockade
por: Deng, Jie, et al.
Publicado: (2016) -
Enhancement of Radiation Therapy through Blockade of the Immune Checkpoint, V-domain Ig Suppressor of T Cell Activation (VISTA), in Melanoma and Adenocarcinoma Murine Models
por: Duval, Kayla E. A., et al.
Publicado: (2023) -
Blocking the VISTA pathway enhances disease progression in (NZB × NZW) F1 female mice
por: Sergent, PA, et al.
Publicado: (2017)